Coronaviruses
The World's First International Journal Dedicated to Coronaviruses
Volume 2, 12 Issues, 2021
ISSN: 2666-7975 (Online)
ISSN: 2666-7967 (Print)
This journal supports open access
Volume 2, 12 Issues, 2021
ISSN: 2666-7975 (Online)
ISSN: 2666-7967 (Print)
This journal supports open access
The publication process of all articles will be expedited, for timely publication of much needed research
Aims & Scope
Coronaviruses publishes original research articles, letters, reviews/mini-reviews, clinical trial and guest edited thematic issues on all aspects of coronaviruses such as their origins, types, transmission, pathogenesis, epidemiological, demographic, clinical and genomic characteristics etc.
The Journal also covers case reports and studies on outbreak of coronaviruses, their symptoms, related diseases, prevention, treatment and development of new therapeutics.
Coronaviruses
,Volume 1
-Number 1
Preface Free Content
Preface
Foreword Free Content
Foreword
Foreword Free Content
Foreword
Letter to the Editor Free Content
A Note on the Potential BCG Vaccination – COVID-19 Molecular Link
, 1(1): 4 - 6Alex Y. Strongin, Alex Sloutsky and Piotr Cieplak*
DOI: 10.2174/2666796701999200629003417
A Note on the Potential BCG Vaccination – COVID-19 Molecular Link
Letter to the Editor Free Content
The COVID-19 and Ageism in Social Media
, 1(1): 7 - 8Yadollah Abolfathi Momtaz*
DOI: 10.2174/2666796701999200621203144
The COVID-19 and Ageism in Social Media
Perspective Free Content
nCovid-19 in 2020: From Despair to Hope
, 1(1): 9 - 12Ravi Varala* and Haribabu Bollikolla
DOI: 10.2174/2666796701999200621202839
nCovid-19 in 2020: From Despair to Hope
Research Article Free Content
Activity of Some Novel Chalcone Substituted 9-anilinoacridines against Coronavirus (COVID-19): A Computational Approach
, 1(1): 13 - 22Rajagopal Kalirajan*
DOI: 10.2174/2666796701999200625210746
Activity of Some Novel Chalcone Substituted 9-anilinoacridines against Coronavirus (COVID-19): A Computational Approach
Review Article Free Content
Potential Immunotherapy against SARS-CoV-2: Strategy and Status
, 1(1): 23 - 31Abid H. Banday*, Shameem A. Shah and Sheikh J. Ajaz
DOI: 10.2174/2666796701999200625212040
Potential Immunotherapy against SARS-CoV-2: Strategy and Status
Coronaviruses, Volume 2 (2021) - Number 1
This issue is in progress but contains articles that are final and fully citable.
Preface Open Access
Preface
Letter to the Editor Open Access
Vitamin D3 Deficiency and COVID-19
, 2(1): 2 - 3Olen R. Brown* and Martin R. Hullender
DOI: 10.2174/2666796701999200914112352
Vitamin D3 Deficiency and COVID-19
Letter to the Editor
Dengue, Influenza and COVID-19 in Brazil: The “Perfect Storm”
, 2(1): 4 - 5Rosineide Marques Ribas*, Paola Amaral de Campos, Cristiane Silveira de Brito and Paulo Pinto Gontijo Filho
DOI: 10.2174/2666796701666200818101458
Dengue, Influenza and COVID-19 in Brazil: The “Perfect Storm”
SHORT COMMUNICATION Open Access
Amantadine Might be Used as a Drug for SARS-Cov-2 Treatment?
, 2(1): 6 - 7Zeynep Gunes Ozunal and Sevki Sahin*
DOI: 10.2174/2666796701999200713192912
Amantadine Might be Used as a Drug for SARS-Cov-2 Treatment?
Perspective Article
Synthetic Lung Surfactant Treatment for Covid-19 Pneumonia
, 2(1): 8 - 10Frans J. Walther* and Alan J. Waring
DOI: 10.2174/2666796701999201014160428
Synthetic Lung Surfactant Treatment for Covid-19 Pneumonia
Perspective Open Access
Insights into the Positive Role of a Higher Education Institution in the Prevention of Misinformation During Pandemics: The Health Committee Model During COVID-19
, 2(1): 11 - 17Dalal Hammoudi Halat*, Marwan Akel, Fatima Hajj, Hassan HajjHussein, Rawad Kansoun, Ehsan Sharif-Askari, Lama Siblani and Ahmad Faraj
DOI: 10.2174/2666796701999200915145332
Insights into the Positive Role of a Higher Education Institution in the Prevention of Misinformation During Pandemics: The Health Committee Model During COVID-19
Perspective
Favipiravir in the Spotlight: In Search of Treatment against COVID-19
, 2(1): 18 - 26Victor Facchinetti and Marcus Vinícius Nora de Souza*
DOI: 10.2174/2666796701999200729155347
Favipiravir in the Spotlight: In Search of Treatment against COVID-19
Opinion Article Open Access
Dealing with COVID-19: Lessons Learned from the Italian Experience
, 2(1): 27 - 29Silvana Mirella Aliberti*, Francesco De Caro, Giovanni Boccia, Rosario Caruso and Mario Capunzo
DOI: 10.2174/2666796701999200908094136
Dealing with COVID-19: Lessons Learned from the Italian Experience
Articles Ahead of Print
Impact of Novel Coronavirus (COVID-19) on Pregnant Women: A Review
Saima Habeeb* and Manju Chugani
DOI: 10.2174/2666796701999201116123457
View Abstract
COVID-19: A Daily Dose of Yoga to Cope with Anxiety
Surabhi Gautam and Rima Dada*
DOI: 10.2174/2666796701999201123102216
View Abstract
Safety and Efficacy of Convalescent Plasma Therapy for the Management of COVID-19: A Systematic Review
Sitaram Khadka*, Muhammad Saleem, Dhan Bahadur Shrestha and Pravash Budhathoki
DOI: 10.2174/2666796701999201204114525
View Abstract
Psychological Impact of Coronavirus (COVID-19) Disease on Cancer Patients
Gaurav Dhiman*
DOI: 10.2174/2666796701999210101151035
View Abstract
Psychological and Mental Health Issues During the SARS-CoV-2 Global Pandemic: A Critical Analysis
Tahmeena Khan*, Iqbal Azad and Alfred J. Lawrence
DOI: 10.2174/2666796701999201117103132
View Abstract
Pleiotropic effects of Nitric Oxide on SARS-CoV-2 Infections
Barbara Terroni, Juliana Romano Lopes, Chung Man Chin and Jean Leandro Dos Santos*
DOI: 10.2174/2666796701999201230121515
View Abstract
A critical appraisal of the risk of bias in systematic reviews and metaanalyses pertaining to COVID-19
Amit Dang*, Sheshank Madiraju, Jagan Mohan Venkateswara Rao P, Navya Sri Gurram, Sandeep Digijarala, Sumit Dang and Vallish BN
DOI: 10.2174/2666796701666201230105144
View Abstract
2019 Novel Coronavirus: A review on Epidemiology, Pathophysiology, Diagnosis and Current Clinical Trials in Vaccine Development
Megala Jayaraman*, Sabari Krishna B. B., Parijat Dutta, Jayesh Telang, Sreshta Adhikari and Arpan Neeraj Pardeshi
DOI: 10.2174/2666796701666201230104321
View Abstract
Repositioning of Drugs as a promising strategy to fight COVID-19
Vivek Yadav, Jurnal Reang, Vinita Sharma, Jaseela Majeed, Swaminathan Jambulingam, Ramesh Goyal and Rajiv Kumar Tonk*
DOI: 10.2174/2666796701666201230103558
View Abstract
Chemi-Informatic Approach to Investigate Putative Pharmacoactive Agents of Plant Origin to Eradicate COVID-19
Amit Joshi, Vandna Sharma, Joginder Singh and Vikas Kaushik
DOI: 10.2174/2666796701999201203210036
View Abstract
Abstracts Ahead of Print
There are currently no Abstracts Ahead of Print available for this journal.
Published Contents
Editor's Choice
Potential Drug Options for Treatment of COVID-19: A Review
, 2020; 1(1): 42 - 48Tinsae Kebede, Dharmendra Kumar* and Pramod Kumar Sharma
DOI: 10.2174/2666796701999200701131604
Open Access Articles
Dealing with COVID-19: Lessons Learned from the Italian Experience
, 2020; 1: 1 - 3 (E-Pub Ahead of Print)Silvana Mirella Aliberti*, Francesco De Caro, Giovanni Boccia, Rosario Caruso and Mario Capunzo
Most Cited Articles
Most Accessed Articles
COVID-19: Morphology, Characteristics, Symptoms, Prevention, Clinical Diagnosis and Current Scenario
, 2020; 1(1): 82-89.Tansukh Barupal, Praveen Kumar Tak and Mukesh Meena*
DOI: 10.2174/2666796701999200617161348
A Note on the Potential BCG Vaccination – COVID-19 Molecular Link
, 2020; 1(1): 4-6.Alex Y. Strongin, Alex Sloutsky and Piotr Cieplak*
DOI: 10.2174/2666796701999200629003417
Potential Immunotherapy against SARS-CoV-2: Strategy and Status
, 2020; 1(1): 23-31.Abid H. Banday*, Shameem A. Shah and Sheikh J. Ajaz
DOI: 10.2174/2666796701999200625212040
Activity of Some Novel Chalcone Substituted 9-anilinoacridines against Coronavirus (COVID-19): A Computational Approach
, 2020; 1(1): 13-22.Rajagopal Kalirajan*
DOI: 10.2174/2666796701999200625210746
The COVID-19 and Ageism in Social Media
, 2020; 1(1): 7-8.Yadollah Abolfathi Momtaz*
DOI: 10.2174/2666796701999200621203144
nCovid-19 in 2020: From Despair to Hope
, 2020; 1(1): 9-12.Ravi Varala* and Haribabu Bollikolla
DOI: 10.2174/2666796701999200621202839
A Preliminary Review on Novel Coronavirus Disease: COVID-19
, 2020; 1(1): 90-97.Miranji Katta*, Satish Rapaka, Ramkumar Adireddi and Jagadeeshwara Rao Emandi
DOI: 10.2174/2666796701999200615155630
Potential Drug Options for Treatment of COVID-19: A Review
, 2020; 1(1): 42-48.Tinsae Kebede, Dharmendra Kumar* and Pramod Kumar Sharma
DOI: 10.2174/2666796701999200701131604
Revealing Potential Binding Affinity of FDA Approved Therapeutics Targeting Main Protease (3CLpro) in Impairing Novel Coronavirus (SARSCoV- 2) Replication that Causes COVID-19
, 2020; 1(1): 98-107.D. Sivaraman*, P.S. Pradeep, S. Sundar Manoharan, C. Ramachandra Bhat, K.V. Leela and V. Venugopal
DOI: 10.2174/2666796701999200701122817
COVID-19: Could Irisin Become the Handyman Myokine of the 21st Century?
, 2020; 1(1): 32-41.Alessia Catalano*
DOI: 10.2174/2666796701999200617154655
Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach
, 2020; 1(1): 73-81.Sibi Raj, Vaishali Chandel, Brijesh Rathi and Dhruv Kumar*
DOI: 10.2174/2666796701999200617155013
Repurposing of RdRp Inhibitors against SARS-CoV-2 through Molecular Docking Tools
, 2020; 1(1): 108-116.Rohit Bhatia*, Raj Kumar Narang and Ravindra Kumar Rawal
DOI: 10.2174/2666796701999200617155629
The Comprehensive Appraisal of COVID-19: Its’ Clinical Panorama from Virology till Management and Beyond
, 2020; 1(1): 57-72.Iftikhar Haider Naqvi* and Saiyeda Nayema Zehra Rizvi
DOI: 10.2174/2666796701999200701132336
Editor-in-Chief
Jean-Marc Sabatier
Institute of NeuroPhysiopathology
Marseille, Cedex
(France)
Biography
Institute of NeuroPhysiopathology
Marseille, Cedex
Biography
Biography of Jean-Marc Sabatier
Jean-Marc SABATIER is a Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He headed several academic research teams (CNRS, INSERM and University), as well as a combined academic-industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a Consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins. He so far contributed to several books in toxinology and virology, and more than 160 scientific articles, 180 communications, and 53 patents in both biology and chemistry.
Honorary Senior Advisors
Ferid Murad
(USA)
Atta-ur-Rahman, FRS
(UK)
About the Journal
For Authors
For Librarians & Readers
Quick Links
Advertisement
Webmaster Contact: info@benthamscience.net